BioNotebook: NephroGenex, MediWound, BioDelivery and Biolojic/MedImmune
This article was originally published in Scrip
Executive Summary
NephroGenex prices, MediWound files for IPO; BioDelivery raises $60m; and Biolojic, MedImmune sign research agreement.